Skip to main content

RT @RichardPAConway: Askanase et al. Phase 2 RCT Cenerimod (S1P modulator) in SLE. Primary endpoint not met. Some sugges

Nov 14, 2022 10:44 am
Social Author Name
Richard Conway
Tweet Content
Askanase et al. Phase 2 RCT Cenerimod (S1P modulator) in SLE. Primary endpoint not met. Some suggestion of efficacy at highest 4mg dose. But if its already like this in a phase 2, I doubt a phase 3 will bring better results @RheumNow #ACR22 Abstr#1656 https://t.co/p4fcKW3cYD https://t.co/ha8xqeW6Xk
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×